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Summary
Cerebral venous thrombosis (CVT) is an 
uncommon clinical problem and can be 
characterised by nonspecific and common 
symptoms of headaches and vomiting due 
to the intracranial hypertension. Alternate 
diagnoses are entertained especially when 
procoagulant factors are not elicited. We present 
a 35 year old female, parity 2+0, gravida 3 at 8 
weeks gestation who presented with headache, 
vomiting, photophobia and neck stiffness. The 
diagnostic workup and radiological findings 
confirmed multiple venous sinus thromboses. 
The case is discussed in the light of diagnostic 
challenge, treatment pathways and how an 
understanding of the basic sciences explains its 
clinical presentation. 
The diagnosis of cerebral venous sinus 
thrombosis should be considered in a young 
patient presenting with an unusual headache in 
the absence the usual vascular risk factors.
Introduction
Cerebral venous thrombosis is an uncommon 
disease that presents in a non-specific pattern. 
Ninety percent of patients report a headache, 
50% have some type of neurological deficit and 
convulsions occur in 40% of cases (1). This non-
specific presentation leads to misdiagnosis, 
delayed diagnosis or medical misadventures. 
Average delay from onset of symptoms to 
diagnosis is 7 days (2).
The patient profile is varied, defining 
clinical characteristics few and  aetiological 
relationships diverse. Documented series 
indicate association of sinus thrombosis with 
presence of prothromotic factors (3), genetic 
factors including protein C and S deficiency, 
pregnancy, nephrotic syndrome as well as 
dehydration and cancer (4).
A clinician’s high index of suspicion remains 
the vanguard of making an accurate and timely 
diagnosis. We report a case of a young female 
who presented with non-specific symptoms 
and  signs and managed for multiple cerebral 
venous sinus thrombosis.
Case report
A. N., a 35 year old female patient, at parity 2+0, 
gravida 3 at 8 weeks gestation presented to our 
hospital with 6 days history of a severe global 
throbbing headache of sudden onset that was 
associated with vomiting, photophobia and 
neck stiffness. She had no antecedent trauma, 
fever nor any history of hypertension.
Her obstetric and gynecological history 
was unremarkable, without any use of oral 
contraceptives. She was a married housewife 
who neither smoked nor consumed any alcohol.
On general examination, A.N. was restless 
but had no conjuctival pallor, scleral icterus, 
oral thrush or lymphadenopathy. Her vital 
signs were normal (brachial blood pressure of 
106/65 mmHg, temperature 370C) except for a 
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tachycardia of 106 beats/min (good volume, 
regular non-collapsing pulse). 
She was fully conscious with normal 
higher functions and pupils that were 3 mm in 
diameter and responsive to light, both directly 
and consensually. Positive findings included 
photophobia, a left sided abducent nerve palsy 
and bilateral papilloedema at fundoscopy. 
Her neck was stiff with negative Kerning’s 
and Brudzinki’s signs while the spine, motor, 
sensory and cerebellar examinations were 
unremarkable. The systemic findings were non-
contributory. An impression of a subarachnoid 
hemorrhage with differential diagnosis of 
meningitis and an intracranial space occupying 
lesion were entertained.
Laboratory investigations included a 
haemogram (Hb of 13.7g/dL, WBCs of 8.2x109 
/L with a neutrophil count of 70%) and 
electrolytes (K+ 2.8 mmol/L). The rest of the 
biochemistry, and the coagulation profile were 
unremarkable. The opening pressures were 
high and the CSF bloody at lumbar puncture. 
An MRI was then performed that revealed 
hyperintense signals in the superior sagittal 
sinus (SSS), straight, right transverse and 
sigmoid sinuses-changes due to thrombosis 
(Figure 1). The thrombi were multiple with 
some being contiguous and others discrete.
A thrombophilia screen ordered after this 
showed a normal profile (Table 1).
















Figure 1: T1 MRI images of the patient showing hyperintense signals at multiple sites (block arrows)
The Annals of African Surgery; Vol. 2, June 200844
Her subsequent management entailed 
anticoagulation with high dose enoxaparin and 
treatment with clonazepam, analgesics and 
potassium supplementation. The patient had 
an uneventful recovery and was discharged 
home on the 7th day. She will complete one year 
of anticoagulation.
Discussion
Most of A.N.’s major venous sinuses were 
involved with the exception of the inferior 
saggital. The superior saggittal sinus usually 
drains into the confluence of sinuses then into 
the straight and finally the sigmoid sinus. The 
combination of both continuous and discrete 
thrombi point to either a systemic aetiology or a 
combination of  both local and systemic causes. 
Some anatomic features may explain some of 
the local factors contributing to thrombosis and 
propagation. Sinuses are valveless endothelia-
lined channels formed between the two layers 
of the dura. Endothelial disruptions in these 
low pressure channels (contributing to stasis) 
may initiate or propagate thrombosis (5). 
The cerebral veins join the sinuses obliquely 
generally against the blood stream and create 
regions of turbulent flow. These features may 
point to prothrombotic zones and explain 
thrombus propagation in sinuses in proximity. 
Hence a systemic hypercoagulable state in 
combination with local features may account 
for the varied pattern of thromboses.
This patient had no other procoagulant 
factor other than pregnancy. High circulating 
estrogen levels in pregnancy are accepted to 
be the cause of this hypercoagulable state. In 
general, aetiological relationships of cerebral 
sinus thrombosis are varied. About 85% of 
patients are noted to have a procoagulant  factor 
(3) which may include protein C and S genetic 
deficiencies, pregnancy, nephrotic syndrome as 
well as dehydration and cancer (4). Her age and 
physiological status did not fall into the other 
thrombophilia risk patterns.
Close to 90% of patients report a headache 
with 50% having some type of neurological 
deficit while convulsions occur in 40% of cases 
(1). Headache was present in our patient. This 
symptom, in association with vomiting is a 
feature of intracranial hypertension. Normal 
cerebro-spinal fluid flow patterns have the final 
common pathway as the reabsorption by the 
arachnoid granulations and flow into the venous 
sinuses (6). Thrombosis within the sinuses block 
the CSF flow pathways causing intracranial 
hypertension without ventriculomegaly (Figure 
1). Cerebral vein thrombosis leads to local effects 
of venous hypertension with associated ischemia 
and disruption in the blood brain barrier that 
result in both cytotoxic and vasogenic edema 
(Figure 2), which contribute further to the 
development of intracranial hypertension. These 
distinct but concurrent mechanisms are central 
to the pathophysiology. Large unilateral lesions 
may cause compression of the diencephalon and 
brain stem leading to coma or death.
Cerebral vein thrombosis
Venous infarction
Ischaemic neuronal damage 
with petechial haemorrhages








Figure 1: Description of the course and consequence of venous thrombosis
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The clinical features in our patient varied 
with limited value in terms of localization 
of the lesion. She had features of meningeal 
irritation and abducent nerve palsy. Since the 
sinus drainage areas are wide and varied, the 
neurological signs seen here and described by 
other authors are not surprising.
The diagnosis of CVT is usually confirmed 
on laboratory investigations and radiology. The 
lumbar puncture was performed and revealed 
bloody CSF. This is a sensitive but nonspecific 
marker for cerebral venous thrombosis. The 
fact that our patient was pregnant limited our 
radiological investigation to the MRI since a 
CT scan poses unacceptable radiation risks to 
the fetus. In routine practice the sensitivity of 
CT scan is limited in the initial three days but 
its utility lies in the ability to rapidly rule out 
other important differential diagnoses. MRI 
approaches a sensitivity of up to 98% in some 
series with the current modality of choice 
being Single-slice phase-contrast angiography 
(SSPCA) with a sensitivity of 100% (7).
Treatment of CVT is aimed at stabilization, 
prevention of clot propagation and the 
prevention or reversal of cerebral herniation. 
The management of this patient included 
anticoagulation for the purposes of propagation 
prevention. This role of anticoagulants is 
controversial with the basic concern being that 
40% of patients present with a haemorrhagic 
infarct in situ. Literature available from three 
trials by Einhaupal et al (8), De bruin et al (9) and 
Nagaraja et al (10) provide no clear answers. In all 
these, no increase or new cerebral haemorrhage 
occurred. Two cases of pulmonary embolism 
were reported in the placebo group in two these 
trials.
The duration of anticoagulation is guided 
by the findings that there is a 2% rethrombosis 
and 4% extracranial thrombotic event within a 
year (1). This formed the basis for one year of 
anticoagulation in our patient.
The clinical course of the patient was benign 
with self-limiting disease without need for 
surgery to achieve decompression or use of 
osmotic diuretics (11), as well as endovascular 
placement of thrombolytics (12). The latter is 
considered experimental. Although the patient 
had a lumbar puncture for diagnostic purposes, 
it could also be therapeutic for the treatment 
of intracranial hypertension. If employed, the 
punctures are done serially in combination 
with acetazolamide (13). CSF diversionary 
procedures are indicated after two weeks 
of failed conservative therapy with serial 
lumbar punctures. The options include lumbar 
peritoneal shunt or fenestration of the optic 
nerve sheath (14).
In conclusion, this patient’s non-specific 
clinical picture belies the challenge in diagnosis 
and management of this particular condition. 
Although a rare condition, a clinician’s high 
index of suspicion remains the first step towards 
a correct and timely diagnosis. The diagnosis 
of cerebral venous sinus thrombosis should 
be considered in a young and middle-aged 
patient presenting with an unusual headache 
or with stroke-like symptoms without the 
usual vascular risk factors. The worsening of 
the local effect of cerebral venous thrombosis 
is preventable by early anticoagulation.
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Figure 2: Effects of major sinus thrombosis
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